Adiponectin--its potential to predict and prevent coronary artery disease

Area of Science:

• Cardiovascular Science
• Metabolic Research
• Adipokine Signaling

Background:

• Epicardial adipose tissue's role in coronary artery disease (CAD) pathogenesis is increasingly recognized.
• Adiponectin, an adipokine, possesses anti-inflammatory and insulin-sensitizing properties.
• Investigating local and systemic adiponectin in relation to CAD and cardiovascular risk factors is crucial.

Purpose of the Study:

• To determine the relationship between local and systemic adiponectin levels and the presence of coronary artery disease (CAD).
• To explore the correlation between adiponectin and cardiovascular risk factors.
• To assess the potential of adiponectin as a marker for cardiovascular risk monitoring.

Main Methods:

• Serum and adipose tissue samples (subcutaneous and pericoronary) were collected from patients with and without CAD.
• Western blot, ELISA, and PCR were employed to quantify adiponectin concentrations and gene expression.
• Sixty patients undergoing cardiac surgery were included in the study.

Main Results:

• Adiponectin concentrations were significantly higher in serum and pericoronary fat of patients without CAD compared to those with CAD (P < 0.01).
• No significant differences in adiponectin mRNA expression were observed.
• Male gender, BMI > 30, and type 2 diabetes were associated with decreased serum adiponectin (P < 0.03).

Conclusions:

• Pericoronary fat actively secretes metabolically active adiponectin.
• Inverse correlation between adiponectin concentrations and CAD presence highlights its anti-atherogenic effects.
• Adiponectin may serve as a valuable marker for monitoring cardiovascular risk factors and guiding secondary prevention in CAD patients.